Stock & Company Details
Greenwich LifeSciences Inc $GLSI
Price:
N/A
N/A
15M
$222M
52 Week High:
N/A
10 Day Average Volume:
N/A
-9.69
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
GLSI technical indicators
Latest Greenwich LifeSciences Inc (GLSI) indicator readings as of 2026-10-09.
GLSI's 14-day RSI is 48.1, in neutral territory. At $16.53 it is trading 24.9% below its 200-day moving average of $22.00, and above its 50-day average of $16.46. Price sits in the middle of its Bollinger Bands ($14.75 to $19.86). ADX reads 16.9, indicating a range-bound market rather than a trend.
Overview
Greenwich LifeSciences Inc is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. Its Product Candidates include; GP2, a HER2/neu transmembrane peptide that elicits a targeted immune response against HER2/neu-expressing cancers, GM-CSF Immunoadjuvant has been shown to enhance monocyte and neutrophil cytotoxicity against melanoma tumor cells and to enhance activity-dependent cellular cytotoxicity of monocytes and neutrophils against targets coated with the anti-ganglioside antibodies, and Cancer immunotherapy seeks to stimulate an individual's immune system to selectively attack cancer cells in order to inhibit the spread of cancer.
Finance Bot
Ask your questions
Start by typing a question below.
